Metraipolis › archive › dc_44a66e5ff15a

Anti-HPV gel versus interferon α-2b gel as adjuvant therapy after LEEP for HSIL with HR-HPV infection on clinical outcomes, vaginal microecology, and… — Europe PMC PMID:41959911

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41959911
DOI
10.3389/fonc.2026.1784137
License (as archived)
solo-consultazione
Archived
2026-11-03T22:20:36.667Z
SHA-256 of the archived text
d2e4dc8d284b6675c89d28a7e03b6cb65540e31ca43ac71ebf1942907ec36df5
Stable URL of this page
https://metraipolis.com/documento/dc_44a66e5ff15a

How to cite

Anti-HPV gel versus interferon α-2b gel as adjuvant therapy after LEEP for HSIL with HR-HPV infection on clinical outcomes, vaginal microecology, and… — Europe PMC PMID:41959911 — Europe PMC (en), https://europepmc.org/article/MED/41959911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_44a66e5ff15a (Metraipolis archive dc_44a66e5ff15a, sha256 d2e4dc8d284b6675c89d28a7e03b6cb65540e31ca43ac71ebf1942907ec36df5)
BibTeX
@misc{dc44a66e5ff15a,
  title = {Anti-HPV gel versus interferon α-2b gel as adjuvant therapy after LEEP for HSIL with HR-HPV infection on clinical outcomes, vaginal microecology, and… — Europe PMC PMID:41959911},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41959911},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_44a66e5ff15a; sha256 d2e4dc8d284b6675c89d28a7e03b6cb65540e31ca43ac71ebf1942907ec36df5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41959911. Agents can read the archived copy with the MCP tool read_document.